Other Species / Isoforms
  Cbl-b (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R8-m1
MANSMNGrNPGGrGG
0 1
Cbl-b (human) MANSMNGrNPGGrGG R8-m1
Cbl-b iso2 (human) MANSMNGRNPGGRGG R8
Cbl-b (mouse) MANSMNGRNPGGRGG R8
Cbl-b (rat) MANSMNGRNPGGRGG R8
R13-m1
NGrNPGGrGGNPrKG
0 2
Cbl-b (human) NGrNPGGrGGNPrKG R13-m1
Cbl-b iso2 (human) NGRNPGGRGGNPRKG R13
Cbl-b (mouse) NGRNPGGRGGNPRKG R13
Cbl-b (rat) NGRNPGGRGGNPRKG R13
R18-m1
GGrGGNPrKGRILGI
0 1
Cbl-b (human) GGrGGNPrKGRILGI R18-m1
Cbl-b iso2 (human) GGRGGNPRKGRILGI R18
Cbl-b (mouse) GGRGGNPRKGRILGI R18
Cbl-b (rat) GGRGGNPRKGRILGI R18
K64-ub
VRLCQNPkLQLKNSP
0 2
Cbl-b (human) VRLCQNPkLQLKNSP K64-ub
Cbl-b iso2 (human) VRLCQNPKLQLKNSP K64
Cbl-b (mouse) VRLCQNPKLQLKNSP K64
Cbl-b (rat) VRLCQNPKLQLKNSP K64
Y92-p
LRLILSKyDDNQkLA
0 2
Cbl-b (human) LRLILSKyDDNQkLA Y92-p
Cbl-b iso2 (human) LRLILSKYDDNQKLA Y92
Cbl-b (mouse) LRLILSKYDDNQKLA Y92
Cbl-b (rat) LRLILSKYDDNQKLA Y92
K97-ub
SKyDDNQkLAQLSEN
0 1
Cbl-b (human) SKyDDNQkLAQLSEN K97-ub
Cbl-b iso2 (human) SKYDDNQKLAQLSEN K97
Cbl-b (mouse) SKYDDNQKLAQLSEN K97
Cbl-b (rat) SKYDDNQKLAQLSEN K97
Y106-p
AQLSENEyFKIYIDS
Downstream
1 2
Effects on Modified Protein
  • enzymatic activity, induced
  • ubiquitination
Cbl-b (human) AQLSENEyFKIYIDS Y106-p
Cbl-b iso2 (human) AQLSENEYFKIYIDS Y106
Cbl-b (mouse) AQLSENEYFKIYIDS Y106
Cbl-b (rat) AQLSENEYFKIYIDS Y106
Y133-p
KEGKERMyEEQSQDR
Downstream
1 0
Effects on Modified Protein
  • enzymatic activity, induced
  • ubiquitination
Cbl-b (human) KEGKERMyEEQSQDR Y133-p
Cbl-b iso2 (human) KEGKERMYEEQSQDR Y133
Cbl-b (mouse) KEGKERMYEEQSQDR Y133
Cbl-b (rat) KEGKERMYEEQSQDR Y133
Y276-p
VKARLQKysTKPGsY
0 1
Cbl-b (human) VKARLQKysTKPGsY Y276-p
Cbl-b iso2 (human) VKARLQKYSTKPGSY Y276
Cbl-b (mouse) VKARLQKYSTKPGSY Y276
Cbl-b (rat) VKARLQKYSTKPGSY Y276
S277-p
KARLQKysTKPGsYI
0 1
Cbl-b (human) KARLQKysTKPGsYI S277-p
Cbl-b iso2 (human) KARLQKYSTKPGSYI S277
Cbl-b (mouse) KARLQKYSTKPGSYI S277
Cbl-b (rat) KARLQKYSTKPGSYI S277
S282-p
KysTKPGsYIFRLSC
Upstream
1 0
Kinase, in vitro:
  • PKCT (human)
Cbl-b (human) KysTKPGsYIFRLSC S282-p
Cbl-b iso2 (human) KYSTKPGSYIFRLSC S282
Cbl-b (mouse) KYSTKPGSYIFRLSC S282
Cbl-b (rat) KYSTKPGSYIFRLSC S282
Y337-p
LYPDGRSyNPDLTGL
0 3
Cbl-b (human) LYPDGRSyNPDLTGL Y337-p
Cbl-b iso2 (human) LYPDGRSYNPDLTGL Y337
Cbl-b (mouse) LYPDGRSYNPDLTGL Y337
Cbl-b (rat) LYPDGRSYNPDLTGL Y337
Y360-p
IKVTQEQyELyCEMG
0 4
Cbl-b (human) IKVTQEQyELyCEMG Y360-p
Cbl-b iso2 (human) IKVTQEQYELYCEMG Y360
Cbl-b (mouse) IKVTQEQYELYCEMG Y360
Cbl-b (rat) IKVTQEQYELYCEMG Y360
Y363-p
TQEQyELyCEMGSTF
Downstream
2 82
Effects on Modified Protein
  • enzymatic activity, induced
  • ubiquitination
Cbl-b (human) TQEQyELyCEMGSTF Y363-p
Cbl-b iso2 (human) TQEQYELYCEMGSTF Y363
Cbl-b (mouse) TQEQYELYCEMGSTF Y363
Cbl-b (rat) TQEQYELYCEMGSTF Y363
T471-p
LANVRKCtDRQNsPV
0 1
Cbl-b (human) LANVRKCtDRQNsPV T471-p
Cbl-b iso2 (human) LANVRKCTDRQNSPV T471
Cbl-b (mouse) LASVRKCTDRQNsPV T471
Cbl-b (rat) LASVRKCTDRQNsPV T471
S476-p
KCtDRQNsPVtsPGs
1 20
Cbl-b (human) KCtDRQNsPVtsPGs S476-p
Cbl-b iso2 (human) KCTDRQNSPVTSPGS S476
Cbl-b (mouse) KCTDRQNsPVtsPGs S476-p
Cbl-b (rat) KCTDRQNsPVTSPGs S476-p
T479-p
DRQNsPVtsPGssPL
0 2
Cbl-b (human) DRQNsPVtsPGssPL T479-p
Cbl-b iso2 (human) DRQNSPVTSPGSSPL T479
Cbl-b (mouse) DRQNsPVtsPGssPL T479-p
Cbl-b (rat) DRQNsPVTSPGsSPL T479
S480-p
RQNsPVtsPGssPLA
1 21
Cbl-b (human) RQNsPVtsPGssPLA S480-p
Cbl-b iso2 (human) RQNSPVTSPGSSPLA S480
Cbl-b (mouse) RQNsPVtsPGssPLA S480-p
Cbl-b (rat) RQNsPVTSPGsSPLA S480
S483-p
sPVtsPGssPLAQRR
0 5
Cbl-b (human) sPVtsPGssPLAQRR S483-p
Cbl-b iso2 (human) SPVTSPGSSPLAQRR S483
Cbl-b (mouse) sPVtsPGssPLAQRR S483-p
Cbl-b (rat) sPVTSPGsSPLAQRR S483-p
S484-p
PVtsPGssPLAQRRk
0 15
Cbl-b (human) PVtsPGssPLAQRRk S484-p
Cbl-b iso2 (human) PVTSPGSSPLAQRRK S484
Cbl-b (mouse) PVtsPGssPLAQRRK S484-p
Cbl-b (rat) PVTSPGsSPLAQRRK S484
K491-ub
sPLAQRRkPQPDPLQ
0 1
Cbl-b (human) sPLAQRRkPQPDPLQ K491-ub
Cbl-b iso2 (human) SPLAQRRKPQPDPLQ K491
Cbl-b (mouse) sPLAQRRKPQPDPLQ K491
Cbl-b (rat) SPLAQRRKPQPDPLQ K491
K516-ub
PRLDLIQkGIVRsPC
0 3
Cbl-b (human) PRLDLIQkGIVRsPC K516-ub
Cbl-b iso2 (human) PRLDLIQKGIVRSPC K516
Cbl-b (mouse) PRLDLIQKGIVrsPC K516
Cbl-b (rat) PRLDLIQKGIVRSPC K516
R520
LIQkGIVRsPCGsPt
0 1
Cbl-b (human) LIQkGIVRsPCGsPt R520
Cbl-b iso2 (human) LIQKGIVRSPCGSPT R520
Cbl-b (mouse) LIQKGIVrsPCGsPt R520-m2
Cbl-b (rat) LIQKGIVRSPCGSPT R520
S521-p
IQkGIVRsPCGsPtG
0 24
Cbl-b (human) IQkGIVRsPCGsPtG S521-p
Cbl-b iso2 (human) IQKGIVRSPCGSPTG S521
Cbl-b (mouse) IQKGIVrsPCGsPtG S521-p
Cbl-b (rat) IQKGIVRSPCGSPTG S521
S525-p
IVRsPCGsPtGsPkS
0 23
Cbl-b (human) IVRsPCGsPtGsPkS S525-p
Cbl-b iso2 (human) IVRSPCGSPTGSPKS S525
Cbl-b (mouse) IVrsPCGsPtGsPKS S525-p
Cbl-b (rat) IVRSPCGSPTGSPKS S525
T527-p
RsPCGsPtGsPkSSP
0 4
Cbl-b (human) RsPCGsPtGsPkSSP T527-p
Cbl-b iso2 (human) RSPCGSPTGSPKSSP T527
Cbl-b (mouse) rsPCGsPtGsPKSSP T527-p
Cbl-b (rat) RSPCGSPTGSPKSSP T527
S529-p
PCGsPtGsPkSSPCM
0 14
Cbl-b (human) PCGsPtGsPkSSPCM S529-p
Cbl-b iso2 (human) PCGSPTGSPKSSPCM S529
Cbl-b (mouse) PCGsPtGsPKSSPCM S529-p
Cbl-b (rat) PCGSPTGSPKSSPCM S529
K531-ub
GsPtGsPkSSPCMVR
0 1
Cbl-b (human) GsPtGsPkSSPCMVR K531-ub
Cbl-b iso2 (human) GSPTGSPKSSPCMVR K531
Cbl-b (mouse) GsPtGsPKSSPCMVR K531
Cbl-b (rat) GSPTGSPKSSPCMVR K531
T601-p
CPRDVFGtNQLVGCR
0 1
Cbl-b (human) CPRDVFGtNQLVGCR T601-p
Cbl-b iso2 (human) CPRDVFGTNQLVGCR T601
Cbl-b (mouse) CPRDAFGTNQVMGCR T600
Cbl-b (rat) CPRDAFGTNQVMGCR T600
S614-p
CRLLGEGsPkPGItA
0 6
Cbl-b (human) CRLLGEGsPkPGItA S614-p
Cbl-b iso2 (human) CRLLGEGSPKPGITA S614
Cbl-b (mouse) CRILGDGSPKPGVTA S613
Cbl-b (rat) CRILGDGSPKPGVTA S613
K616-ub
LLGEGsPkPGItASS
0 2
Cbl-b (human) LLGEGsPkPGItASS K616-ub
Cbl-b iso2 (human) LLGEGSPKPGITASS K616
Cbl-b (mouse) ILGDGSPKPGVTANS K615
Cbl-b (rat) ILGDGSPKPGVTANS K615
T620-p
GsPkPGItASSNVNG
0 1
Cbl-b (human) GsPkPGItASSNVNG T620-p
Cbl-b iso2 (human) GSPKPGITASSNVNG T620
Cbl-b (mouse) GSPKPGVTANSSLNG T619
Cbl-b (rat) GSPKPGVTANSNLNG T619
S634-p
GRHSRVGsDPVLMRK
0 8
Cbl-b (human) GRHSRVGsDPVLMRK S634-p
Cbl-b iso2 (human) GRHSRVGSDPVLMRK S634
Cbl-b (mouse) GRHSRMGSEQVLMRK S633
Cbl-b (rat) GRHSRMGsDQVLMRK S633-p
S662-p
FSNGHLGsEEyDVPP
0 3
Cbl-b (human) FSNGHLGsEEyDVPP S662-p
Cbl-b iso2 (human) FSNGHLGSEEYDVPP S662
Cbl-b (mouse) FSNGHLATEEyDVPP T661
Cbl-b (rat) FSNGHLAPEEYDVPP P661
Y665-p
GHLGsEEyDVPPRLs
Upstream
Downstream
3 122
Effects on Modified Protein
  • molecular association, regulation
Treatment
  • anti-CD3
Cbl-b (human) GHLGsEEyDVPPRLs Y665-p
Cbl-b iso2 (human) GHLGSEEYDVPPRLS Y665
Cbl-b (mouse) GHLATEEyDVPPRLs Y664-p
Cbl-b (rat) GHLAPEEYDVPPRLS Y664
S672-p
yDVPPRLsPPPPVtt
0 99
Cbl-b (human) yDVPPRLsPPPPVtt S672-p
Cbl-b iso2 (human) YDVPPRLSPPPPVTT S672
Cbl-b (mouse) yDVPPRLsPPPPVtt S671-p
Cbl-b (rat) YDVPPRLSPPPPVTA S671
T678-p
LsPPPPVttLLPSIK
0 2
Cbl-b (human) LsPPPPVttLLPSIK T678-p
Cbl-b iso2 (human) LSPPPPVTTLLPSIK T678
Cbl-b (mouse) LsPPPPVttLLPSIK T677-p
Cbl-b (rat) LSPPPPVTALLPSIK T677
T679-p
sPPPPVttLLPSIKC
0 2
Cbl-b (human) sPPPPVttLLPSIKC T679-p
Cbl-b iso2 (human) SPPPPVTTLLPSIKC T679
Cbl-b (mouse) sPPPPVttLLPSIKC T678-p
Cbl-b (rat) SPPPPVTALLPSIKC A678
S693-p
CTGPLANsLSEktRD
0 1
Cbl-b (human) CTGPLANsLSEktRD S693-p
Cbl-b iso2 (human) CTGPLANSLSEKTRD S693
Cbl-b (mouse) CTGPLANCLSEKTRD C692
Cbl-b (rat) CTGPIANCLSEKTRD C692
K697-ub
LANsLSEktRDPVEE
0 1
Cbl-b (human) LANsLSEktRDPVEE K697-ub
Cbl-b iso2 (human) LANSLSEKTRDPVEE K697
Cbl-b (mouse) LANCLSEKTRDTVED K696
Cbl-b (rat) IANCLSEKTRDTVEE K696
T698-p
ANsLSEktRDPVEED
0 1
Cbl-b (human) ANsLSEktRDPVEED T698-p
Cbl-b iso2 (human) ANSLSEKTRDPVEED T698
Cbl-b (mouse) ANCLSEKTRDTVEDD T697
Cbl-b (rat) ANCLSEKTRDTVEED T697
Y709-p
VEEDDDEyKIPSSHP
Upstream
Downstream
3 119
Effects on Modified Protein
  • molecular association, regulation
Treatment
  • anti-CD3
Cbl-b (human) VEEDDDEyKIPSSHP Y709-p
Cbl-b iso2 (human) VEEDDDEYKIPSSHP Y709
Cbl-b (mouse) VEDDDDEyKIPSSHP Y708-p
Cbl-b (rat) VEEDDDEyKIPSSHP Y708-p
S735-p
NVKPPVRsCDNGHCM
0 1
Cbl-b (human) NVKPPVRsCDNGHCM S735-p
Cbl-b iso2 (human) NVKPPVRSCDNGHCM S735
Cbl-b (mouse) NVKAPVRSCDNGHCI S734
Cbl-b (rat) NVKPPVRSCDNGHCI S734
Y763-p
NIPDLSIyLKGDVFD
0 20
Cbl-b (human) NIPDLSIyLKGDVFD Y763-p
Cbl-b iso2 (human) NIPDLSIYLKGDVFD Y763
Cbl-b (mouse) NIPDLGIyLKGGGSD Y763-p
Cbl-b (rat) NIPDLGIYLKGEDAF Y763
N788
ARPPTRDNPkHGSSL
0 2
Cbl-b (human) ARPPTRDNPkHGSSL N788
Cbl-b iso2 (human) ARPPTRDNPKHGSSL N788
Cbl-b (mouse) ARPPPRDsPKHGSSV S788-p
Cbl-b (rat) gap -
K790-ub
PPTRDNPkHGSSLNR
0 1
Cbl-b (human) PPTRDNPkHGSSLNR K790-ub
Cbl-b iso2 (human) PPTRDNPKHGSSLNR K790
Cbl-b (mouse) PPPRDsPKHGSSVNR K790
Cbl-b (rat) under review -
T798-p
HGSSLNRtPSDyDLL
0 1
Cbl-b (human) HGSSLNRtPSDyDLL T798-p
Cbl-b iso2 (human) HGSSLNRTPSDYDLL T798
Cbl-b (mouse) HGSSVNRTPSDYDLL T798
Cbl-b (rat) gap -
Y802-p
LNRtPSDyDLLIPPL
0 1
Cbl-b (human) LNRtPSDyDLLIPPL Y802-p
Cbl-b iso2 (human) LNRTPSDYDLLIPPL Y802
Cbl-b (mouse) VNRTPSDYDLLIPPL Y802
Cbl-b (rat) gap -
K837-ub
HSLIEHSkPPGSSSR
0 1
Cbl-b (human) HSLIEHSkPPGSSSR K837-ub
Cbl-b iso2 (human) under review -
Cbl-b (mouse) HSLIEHSKPPGSSSR K837
Cbl-b (rat) HSLIEHSKPPGSSSR K793
K881-ub
RLPGENVktNRtsQD
0 3
Cbl-b (human) RLPGENVktNRtsQD K881-ub
Cbl-b iso2 (human) gap -
Cbl-b (mouse) RAAGDSGKANRAsQD K881
Cbl-b (rat) RAPGDGVKsNRAsQD K837
T882-p
LPGENVktNRtsQDy
0 4
Cbl-b (human) LPGENVktNRtsQDy T882-p
Cbl-b iso2 (human) gap -
Cbl-b (mouse) AAGDSGKANRAsQDy A882
Cbl-b (rat) APGDGVKsNRAsQDy S838-p
T885-p
ENVktNRtsQDyDQL
0 10
Cbl-b (human) ENVktNRtsQDyDQL T885-p
Cbl-b iso2 (human) gap -
Cbl-b (mouse) DSGKANRAsQDyDQL A885
Cbl-b (rat) DGVKsNRAsQDyDQL A841
S886-p
NVktNRtsQDyDQLP
0 24
Cbl-b (human) NVktNRtsQDyDQLP S886-p
Cbl-b iso2 (human) gap -
Cbl-b (mouse) SGKANRAsQDyDQLP S886-p
Cbl-b (rat) GVKsNRAsQDyDQLP S842-p
Y889-p
tNRtsQDyDQLPsCs
Upstream
2 453
Treatment
  • EGF
  • erlotinib
  • Su11274
Cbl-b (human) tNRtsQDyDQLPsCs Y889-p
Cbl-b iso2 (human) gap -
Cbl-b (mouse) ANRAsQDyDQLPSss Y889-p
Cbl-b (rat) sNRAsQDyDQLPSSS Y845-p
S894-p
QDyDQLPsCsDGsQA
0 9
Cbl-b (human) QDyDQLPsCsDGsQA S894-p
Cbl-b iso2 (human) gap -
Cbl-b (mouse) QDyDQLPSssDGSQA S894
Cbl-b (rat) QDyDQLPSSSDGSQA S850
C895
DyDQLPsCsDGsQAP
0 1
Cbl-b (human) DyDQLPsCsDGsQAP C895
Cbl-b iso2 (human) gap -
Cbl-b (mouse) DyDQLPSssDGSQAP S895-p
Cbl-b (rat) DyDQLPSSSDGSQAP S851
S896-p
yDQLPsCsDGsQAPA
0 8
Cbl-b (human) yDQLPsCsDGsQAPA S896-p
Cbl-b iso2 (human) gap -
Cbl-b (mouse) yDQLPSssDGSQAPA S896-p
Cbl-b (rat) yDQLPSSSDGSQAPA S852
S899-p
LPsCsDGsQAPARPP
0 1
Cbl-b (human) LPsCsDGsQAPARPP S899-p
Cbl-b iso2 (human) gap -
Cbl-b (mouse) LPSssDGSQAPARPP S899
Cbl-b (rat) LPSSSDGSQAPARPP S855
K907-ub
QAPARPPkPRPRRTA
0 1
Cbl-b (human) QAPARPPkPRPRRTA K907-ub
Cbl-b iso2 (human) under review -
Cbl-b (mouse) QAPARPPKPRPRRTA K907
Cbl-b (rat) QAPARPPKPRPRRTA K863
S977-p
FAFPPPVsPRLNL__
Upstream
0 5
Treatment
  • ischemia
  • selumetinib
  • vemurafenib
Cbl-b (human) FAFPPPVsPRLNL__ S977-p
Cbl-b iso2 (human) gap -
Cbl-b (mouse) FAFPPPVsPRLNL__ S977-p
Cbl-b (rat) FAFPPPVSPRLNL__ S933